Search
for
Sort by
Research 30 of 1000+
- Metabolic risk in PCOS: phenotype and adiposity impact
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- Androgenic alopecia in men: the significance of genetic, hormonal and metabolic factors (prospective cohort comparative study)
- Association between Alopecia Areata, Psoriasis Vulgaris, Thyroid Disease, and Metabolic Syndrome
- From Reproductive Disorder to Metabolic Syndrome: The Evolution of Polycystic Ovary Syndrome (PCOS) into Polyendocrine Metabolic Ovarian Syndrome (PMOS)
- Zinc metabolism in lethal-milk mice
- Metabolic syndrome and dermatological diseases: association and treatment
- Androgenic alopecia and its association with metabolic syndrome
- Issue Information ‐ TOC
- In this Issue
- Quality of Life Issues in Male Pattern Hair Loss
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- Viewpoint 3
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Disturbance of the Circadian System in Shift Work and Its Health Impact
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Guidelines for the Use of Acitretin in Psoriasis
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- A Scientific Hypothesis on the Role of Nutritional Supplements for Effective Management of Hair Loss and Promoting Hair Regrowth
- Anabolic-Androgenic Steroids and Cardiometabolic Derangements
- A Review of Metabolic Dysregulation in Lymphocytic Cicatricial Alopecia: Exploring the Connections and Therapeutic Implications
- Exploring Emerging Concepts in the Pathophysiology of PCOS: Microbiome Dysbiosis and Immunological Dysregulation
- Polycystic Ovary Syndrome: A Comprehensive Review of Its Clinical Presentation, Comorbidities, Long-Term Complications and Management
- An Overview of Harmful Effects of Polycystic Ovary Syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women
- Changes in the PCOS phenotype with age
- Period problems: disorders of menstruation in adolescents
- The new paradigm for androgenetic alopecia and plant-based folk remedies: 5α-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance
- Androgen excess and post-reproductive health